Sleep disturbances in patients with chronic pain: effectively managing opioid analgesia to improve outcomes

References

• Onen SH, Onen F, Courpron P, et al. How pain and analgesics disturb sleep. Clin J Pain 2005;21:422-31
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Scarisbrick P, England R, et al. Musculoskeletal symptoms and non-REM sleep disturbance in patients with ‘fibrositis syndrome’ and healthy subjects. Psychosom Med 1975;37:341-51
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35-44
   PubMed Web of Science ®Google Scholar
• Tang NK, Wright KJ, Salkovskis PM. Prevalence and correlates of clinical insomnia co-occurring with chronic back pain. J Sleep Res 2007;16:85-95
   PubMed Web of Science ®Google Scholar
• Edwards RR, Almeida DM, Klick B, et al. Duration of sleep contributes to next-day pain report in the general population. Pain 2008;137:202-7
   PubMed Web of Science ®Google Scholar
• Gupta A, Silman AJ, Ray D, et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology 2007;46:666-71
   PubMed Web of Science ®Google Scholar
• Rosenthal M, Moore P, Groves E, et al. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA®): Findings from a pilot study. J Opioid Manag 2007;3:145-54
   PubMedGoogle Scholar
• Dworkin RH, Corbin AE, Young Jr JP, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-83
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42
   PubMed Web of Science ®Google Scholar
• Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 2005;30:374-85
   PubMed Web of Science ®Google Scholar
• Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006;22:681-5
   PubMed Web of Science ®Google Scholar
• Gustorff B, Dorner T, Likar R, et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand 2008;52:132-6
   PubMed Web of Science ®Google Scholar
• Meyer-Rosberg K, Kvarnstrom A, Kinnman E, et al. Peripheral neuropathic pain—a multidimensional burden for patients. Eur J Pain 2001;5:379-89
   PubMed Web of Science ®Google Scholar
• Goldenberg DL. Fibromyalgia and its relation to chronic fatigue syndrome, viral illness and immune abnormalities. J Rheumatol Suppl 1989;19:91-3
   PubMedGoogle Scholar
• Hawker GA, Stewart L, French MR, et al. Understanding the pain experience in hip and knee osteoarthritis—an OARSI/OMERACT initiative. Osteoarthr Cartil 2008;16:415-22
   PubMed Web of Science ®Google Scholar
• Morriss RK, Wearden AJ, Battersby L. The relation of sleep difficulties to fatigue, mood and disability in chronic fatigue syndrome. J Psychosom Res 1997;42:597-605
   PubMed Web of Science ®Google Scholar
• Treharne GJ, Lyons AC, Hale ED, et al. Sleep disruption frequency in rheumatoid arthritis: perceived stress predicts poor outcome over one year. Musculoskeletal Care 2007;5:51-64
   PubMedGoogle Scholar
• Lavie P, Nahir M, Lorber M, et al. Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients. Lack of association between clinical improvement and effects on sleep. Arthritis Rheum 1991;34:655-9
   Google Scholar
• Nicassio PM, Wallston KA. Longitudinal relationships among pain, sleep problems, and depression in rheumatoid arthritis. J Abnorm Psychol 1992;101:514-20
   PubMed Web of Science ®Google Scholar
• McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag 2002;7:75-9
   PubMedGoogle Scholar
• Menefee LA, Frank ED, Doghramji K, et al. Self-reported sleep quality and quality of life for individuals with chronic pain conditions. Clin J Pain 2000;16:290-7
   PubMed Web of Science ®Google Scholar
• Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med 2000;23:1-13
   PubMed Web of Science ®Google Scholar
• Morin CM, Gibson D, Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 1998;14:311-14
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Sleep disorders. In: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic Criteria for Primary Insomnia, 4th edn, Text Revision. Washington, DC: American Psychiatric Association, 2000:597-661
   Google Scholar
• Ohayon MM. Relationship between chronic painful physical condition and insomnia. J Psychiatr Res 2005;39:151-9
   PubMed Web of Science ®Google Scholar
• Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001;5:423-45
   PubMed Web of Science ®Google Scholar
• Turk DC, Dworkin RH, Revicki D, et al. Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain 2008;137:276-85
   PubMed Web of Science ®Google Scholar
• Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008;9:425-32
   PubMed Web of Science ®Google Scholar
• Smith MT, Buenaver LF. Electroencephalographic correlates of pain and sleep interactions in humans. In: Lavigne G, et al., eds. Sleep and Pain. Seattle, WA: IASP Press; 2007:189-91
   Google Scholar
• Wittig RM, Zorick FJ, Blumer D, et al. Disturbed sleep in patients complaining of chronic pain. J Nerv Mental Dis 1982;170:429-31
   PubMed Web of Science ®Google Scholar
• Wilson KG, Watson ST, Currie SR. Daily diary and ambulatory activity monitoring of sleep in patients with insomnia associated with chronic musculoskeletal pain. Pain 1998;75:75-84
   PubMed Web of Science ®Google Scholar
• Marin R, Cyhan T, Miklos W. Sleep disturbance in patients with chronic low back pain. Am J Phys Med Rehabil 2006;85:430-5
   PubMed Web of Science ®Google Scholar
• Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006;22:681-5
   PubMed Web of Science ®Google Scholar
• Sloan EP, Maunder RG, Hunter JJ, et al. Insecure attachment is associated with the alpha-EEG anomaly during sleep. Biopsychosoc Med 2008;2:24-30
   PubMedGoogle Scholar
• Drewes AM, Svendsen L, Jorgsen S. Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Br J Rheumatol 1998;37:71-81
   PubMedGoogle Scholar
• Buysse DJ, Reynolds 3rd CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213
   PubMed Web of Science ®Google Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5
   PubMed Web of Science ®Google Scholar
• Zallek SN, Redenius R, Fisk H, et al. A single question as a sleepiness screening tool. J Clin Sleep Med 2008;4:143-8
   PubMed Web of Science ®Google Scholar
• Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 2007;23:15-22
   PubMed Web of Science ®Google Scholar
• Caldwell JR, Rapoport RJ, Davis JC, et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002;23:278-91
   PubMed Web of Science ®Google Scholar
• Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005;6:357-66
   PubMed Web of Science ®Google Scholar
• Nicholson B, Ross E, Weil A, et al. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Curr Med Res Opin 2006;22:539-50
   PubMed Web of Science ®Google Scholar
• Rauck RL, Bookbinder SA, Bunker TR, et al. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manage 2006;2:325-8, 331-3
   PubMedGoogle Scholar
• Rauck RL, Bookbinder SA, Bunker TR, et al. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manage 2006;2:155-66
   PubMedGoogle Scholar
• Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000;160:853-60
   PubMed Web of Science ®Google Scholar
• Adams EH, Chwiecko P, Ace-Wagoner Y, et al. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions – the ACCPT Study. Pain Pract 2006;6:254-64
   PubMedGoogle Scholar
• Nicholson B, Ross E, Sasaki J, et al. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain. Curr Med Res Opin 2006;22:1503-14
   PubMed Web of Science ®Google Scholar
• Kivitz A, Ma C, Ahdieh H, et al. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006;28:352-64
   PubMed Web of Science ®Google Scholar
• Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005;6:21-8
   PubMed Web of Science ®Google Scholar
• Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8
   PubMed Web of Science ®Google Scholar
• Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999;26:862-9
   PubMed Web of Science ®Google Scholar
• Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003;60:927-34
   PubMed Web of Science ®Google Scholar
• Markenson JA, Croft J, Zhang PG, et al. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005;21:524-35
   PubMed Web of Science ®Google Scholar
• Gammaitoni AR, Galer BS, Lacouture P, et al. Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain. Pain Med 2003;4:21-30
   PubMed Web of Science ®Google Scholar
• Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007;3:455-61
   PubMed Web of Science ®Google Scholar
• Haddox JD, Joranson DE, Angarola RT, et al. The use of opioids for the treatment of chronic pain: a consensus from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997;13:6-8
   PubMed Web of Science ®Google Scholar
• Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 2007;11:35-46
   PubMed Web of Science ®Google Scholar
• Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005;128:1348-56
   PubMed Web of Science ®Google Scholar
• Tashjian RZ, Banerjee R, Bradley MP, et al. Zolpidem reduces postoperative pain, fatigue, and narcotic consumption following knee arthroscopy: a prospective randomized placebo-controlled double-blinded study. J Knee Surg 2006;19:105-111
   PubMedGoogle Scholar
• Walsh JK, Muehlbach MJ, Lauter SA, et al. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. J Rheumatol 1996;23:245-252
   PubMed Web of Science ®Google Scholar
• Moldofsky H, Lue FA, Mously C, et al. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996;23:529-33
   PubMed Web of Science ®Google Scholar
• Gronblad M, Nykannen J, Konttinen Y, et al. Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol 1993;12:186-91
   PubMed Web of Science ®Google Scholar
• Drewes AM, Andreasen A, Jennum P, et al. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20:288-93
   PubMed Web of Science ®Google Scholar
• Lieberman JA. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. J Clin Psychiatry 2007;9:25-31
   Google Scholar
• Roth TJ. Measuring treatment efficacy in insomnia. J Clin Psychiatry 2004;65(Suppl 8):8-12
   Google Scholar